Active Ingredient History

  • Now
Vernakalant is a pharmaceutical drug for the acute conversion of atrial fibrillation, a kind of irregular heartbeat, in form of an intravenous infusion. It has been approved for use in the European Union and the UK since 2010. The US Food and Drug Administration denied approval in 2008 and 2019.   Wikipedia

  • SMILES: COc1ccc(CCO[C@@H]2CCCC[C@H]2N3CC[C@@H](O)C3)cc1OC
  • Mol. Mass: 349.47
  • ALogP: 2.64
  • ChEMBL Molecules:
More Chemistry
(3r)-1-((1r,2r)-2-(2-(3,4-dimethoxyphenyl)ethoxy)cyclohexyl)pyrrolidin-3-ol | brinavess | rsd1235 | rsd 1235 | rsd-1235 | vernakalant | vernakalant hcl | vernakalant hydrochloride | vernakalent hydrochloride


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue